Gene · 442909
Papers1,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells. | Cells | 2024 | 39451191 | PubTator, text mining | PubMed |
| Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells. | Clin Nutr ESPEN | 2024 | 39047867 | PubTator, text mining | PubMed |
| DNMT1-Mediated the Downregulation of FOXF1 Promotes High Glucose-induced Podocyte Damage by Regulating the miR-342-3p/E2F1 Axis. | Cell Biochem Biophys | 2024 | 39014186 | PubTator, text mining | PubMed |
| Exploring the Relationship between MicroRNAs, Intratumoral Microbiota, and Breast Cancer Progression in Patients with and without Metastasis. | Int J Mol Sci | 2024 | 39000198 | PubTator, text mining | PubMed |
| Increased Expression and Prognostic Significance of BYSL in Melanoma. | J Immunother | 2024 | 38980088 | PubTator, text mining | PubMed |
| Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC). | In Vivo | 2024 | 38936941 | PubTator, text mining | PubMed |
| Recent Advances in and Application of Fluorescent Microspheres for Multiple Nucleic Acid Detection. | Biosensors (Basel) | 2024 | 38920569 | PubTator, text mining | PubMed |
| Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR-4/FoxO3 pathway. | Arch Pharm (Weinheim) | 2024 | 38574101 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in intracranial aneurysms. | Noncoding RNA Res | 2024 | 38511055 | PubTator, text mining | PubMed |
| High-throughput RNA sequencing identifies the miRNA expression profile, target genes, and molecular pathways contributing to growth of sporadic vestibular schwannomas. | Acta Neurochir (Wien) | 2024 | 38329606 | PubTator, text mining | PubMed |
| MicroRNA Profiling of the Inflammatory Response after Early and Late Asthmatic Reaction. | Int J Mol Sci | 2024 | 38279356 | PubTator, text mining | PubMed |
| Role of microRNA in colorectal carcinoma (CRC): a narrative review. | Ann Med Surg (Lond) | 2024 | 38222721 | PubTator, text mining | PubMed |
| Role of TNF-α in the Pathogenesis of Migraine. | Pain Res Manag | 2024 | 38213956 | PubTator, text mining | PubMed |
| miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. | Noncoding RNA Res | 2024 | 38035044 | PubTator, text mining | PubMed |
| Plasma circulating microRNAs associated with blood-based immune markers: a population-based study. | Clin Exp Immunol | 2024 | 37950349 | PubTator, text mining | PubMed |
| Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction. | Front Cardiovasc Med | 2023 | 38259314 | PubTator, text mining | PubMed |
| Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review. | Immun Inflamm Dis | 2023 | 38156400 | PubTator, text mining | PubMed |
| A Comparative Analysis of MicroRNA Expression in Mild, Moderate, and Severe COVID-19: Insights from Urine, Serum, and Nasopharyngeal Samples. | Biomolecules | 2023 | 38136554 | PubTator, text mining | PubMed |
| miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD. | Open Med (Wars) | 2023 | 38075030 | PubTator, text mining | PubMed |
| [Research Progress of LncRNA SNHGs in Regulating the Biological Behavior of Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 38061887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442909/papers?page=2